Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01030283 | 10Z-heptadecenoic acid | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 5.71 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 6.19 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 5.48 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 4.58 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 4.89 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 5.88 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 4.35 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 2.32 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | C | 0.0 | BCD100427B001 | 4.61 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | C | 0.5 | BCD100427B003 | 3.82 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | C | 1.0 | BCD100427B007 | 4.41 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | C | 2.0 | BCD100427B011 | 4.65 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | C | 4.0 | BCD100427B015 | 5.67 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | C | 8.0 | BCD100427B019 | 10.1 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | C | 12.0 | BCD100427B023 | 7.21 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | C | 24.0 | BCD100427B027 | 7.24 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 3.64 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 5.65 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 5.15 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 5.43 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 4.92 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 8.01 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 5.98 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | 25OH-Chol | 0.5 | BCD100427B004 | 5.24 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | 25OH-Chol | 1.0 | BCD100427B008 | 6.36 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | 25OH-Chol | 2.0 | BCD100427B012 | 2.81 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | 25OH-Chol | 4.0 | BCD100427B016 | 5.8 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | 25OH-Chol | 8.0 | BCD100427B020 | 4.54 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | 25OH-Chol | 12.0 | BCD100427B024 | 5.68 | pmol/sample |
| LMFA01030283 | 10Z-heptadecenoic acid | 25OH-Chol | 24.0 | BCD100427B028 | 5.26 | pmol/sample |